Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

CPD Inhibitors

CPD, or Carboxypeptidase D, is an enzyme belonging to the carboxypeptidase family. Carboxypeptidases are proteases that cleave amino acid residues from the C-terminal end of proteins and peptides. CPD, specifically, is a metallo-carboxypeptidase, which means it requires a metal ion, usually zinc, for its catalytic activity. Located in the trans-Golgi network, CPD plays an essential role in protein processing, particularly in the maturation of peptide hormones and neuropeptides. By cleaving off basic amino acids from these precursor proteins, CPD helps generate the mature, biologically active forms of these signaling molecules. Given its central role in the production of such signaling peptides, the regulation and activity of CPD are vital for proper cellular communication and overall physiological homeostasis.

Inhibitors targeting CPD would be molecules specifically designed to modulate the enzyme's catalytic activity. By inhibiting CPD, one could potentially impact the processing and maturation of a wide array of peptide hormones and neuropeptides, leading to altered signaling dynamics within the organism. Potential CPD inhibitors might be small molecules that directly bind to the enzyme's active site, preventing substrate access and thus inhibiting catalysis. These molecules could be designed to mimic the enzyme's natural substrates or to bind to crucial residues in the enzyme's active site. Another avenue for inhibition could involve molecules that bind to allosteric sites on CPD, altering its conformation and thereby its activity. Additionally, molecules that interfere with the enzyme's metal ion binding could also serve as effective inhibitors. Studying the effects of CPD inhibition can offer a deeper understanding of its role in peptide processing, its contributions to cellular signaling, and the broader implications of modulating peptide hormone and neuropeptide levels within an organism. Such insights can also inform the broader understanding of protein processing pathways and their regulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bestatin

58970-76-6sc-202975
10 mg
$131.00
19
(3)

Bestatin is a protease inhibitor that might inhibit CPD by blocking its enzymatic activity.

Phosphoramidon

119942-99-3sc-201283
sc-201283A
5 mg
25 mg
$199.00
$632.00
8
(1)

Phosphoramidon inhibits various metalloproteases, and might affect CPD function.

E-64

66701-25-5sc-201276
sc-201276A
sc-201276B
5 mg
25 mg
250 mg
$281.00
$947.00
$1574.00
14
(0)

E-64 inhibits cysteine proteases, and while CPD is not a cysteine protease, off-target effects are possible.

Leupeptin hemisulfate

103476-89-7sc-295358
sc-295358A
sc-295358D
sc-295358E
sc-295358B
sc-295358C
5 mg
25 mg
50 mg
100 mg
500 mg
10 mg
$73.00
$148.00
$316.00
$499.00
$1427.00
$101.00
19
(3)

Leupeptin is a general protease inhibitor, which could potentially inhibit CPD activity.

AEBSF hydrochloride

30827-99-7sc-202041
sc-202041A
sc-202041B
sc-202041C
sc-202041D
sc-202041E
50 mg
100 mg
5 g
10 g
25 g
100 g
$65.00
$122.00
$428.00
$851.00
$1873.00
$4994.00
33
(1)

AEBSF is a broad-spectrum serine protease inhibitor, which could potentially affect CPD.

1,10-Phenanthroline

66-71-7sc-255888
sc-255888A
2.5 g
5 g
$23.00
$32.00
(0)

A metal chelating agent that can inhibit metalloproteases, potentially impacting CPD.

Aprotinin

9087-70-1sc-3595
sc-3595A
sc-3595B
10 mg
100 mg
1 g
$112.00
$408.00
$3000.00
51
(2)

A broad-spectrum protease inhibitor, which could potentially inhibit CPD activity.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG132 inhibits proteasomal degradation and could indirectly affect CPD levels or activity.

Phenylmethylsulfonyl Fluoride

329-98-6sc-3597
sc-3597A
1 g
100 g
$50.00
$697.00
92
(1)

PMSF is a serine protease inhibitor, which could potentially affect CPD activity.